EverSource Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.9K Buy
694
+390
+128% +$4.97K ﹤0.01% 2976
2025
Q4
$2.73K Sell
304
-231
-43% -$3.18K ﹤0.01% 3382
2025
Q3
$9.24K Buy
535
+73
+16% +$899 ﹤0.01% 2866
2025
Q2
$4.33K Buy
462
+57
+14% +$468 ﹤0.01% 3220
2025
Q1
$2.88K Buy
405
+135
+50% +$1.36K ﹤0.01% 2747
2024
Q4
$3.15K Sell
270
-1,477
-85% -$23.1K ﹤0.01% 2539
2024
Q3
$35.9K Sell
1,747
-6
-0.3% -$138 ﹤0.01% 1208
2024
Q2
$45.9K Buy
1,753
+1,550
+764% +$36.9K ﹤0.01% 1126
2024
Q1
$4.34K Buy
203
+1
+0.5% +$28 ﹤0.01% 2108
2023
Q4
$6.16K Buy
202
+40
+25% +$1.15K ﹤0.01% 1772
2023
Q3
$5.12K Buy
162
+96
+145% +$3.72K ﹤0.01% 1704
2023
Q2
$2.69K Buy
+66
New +$2.68K ﹤0.01% 1948
2022
Q2
Sell
-44
Closed -$3K 1836
2022
Q1
$3K Hold
44
﹤0.01% 1434
2021
Q4
$5K Buy
+44
New +$5.51K ﹤0.01% 1269

Other funds holding NTLA